Diametric Capital’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.8M Buy
9,269,926
+2,468,138
+36% +$10.7M 5.57% 2
2026
Q1
$26.3M Buy
6,801,788
+2,954,764
+77% +$12.1M 6.84% 1
2025
Q4
$16.1M Buy
3,847,024
+2,872,796
+295% +$11.1M 4.31% 1
2025
Q3
$3.21M Buy
974,228
+639,171
+191% +$1.8M 1.19% 11
2025
Q2
$476K Buy
+335,057
New +$476K 0.25% 111
2024
Q1
Sell
-48,518
Closed -$65K 386
2023
Q4
$65K Buy
+48,518
New +$57K 0.04% 239

Other funds holding PGEN

Diametric Capital's PGEN Position: Q2 2026 in Review

Diametric Capital increased its Precigen (PGEN) stake by 36% in Q2 2026, buying an estimated $10.7M and bringing the position to 9,269,926 shares worth $52.8M. The position accounts for 5.57% of the portfolio, ranked #2.

Diametric Capital first reported a position in PGEN in Q4 2023 and has held it in 6 quarters since. 210 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Diametric Capital held 9,269,926 shares of Precigen worth $52.8M as of Q2 2026.
  • Diametric Capital bought 2,468,138 Precigen shares in Q2 2026, an estimated $10.7M.
  • Precigen made up 5.57% of Diametric Capital's portfolio in Q2 2026, its #2 holding.
  • Diametric Capital first reported a position in Precigen in Q4 2023 and has held it in 6 quarters since.
  • 210 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Diametric Capital's 13F filing for Q2 2026, filed 14 Aug 2026.